Utilizing a single-cell technique and various transgenic mouse models, we can conduct an in-depth comparison of the tumor microenvironment components between p53-mutated and p53-loss pancreatic tumors, both in the context of oncogenic KRASG12D-driven PDAC. The gene discussed is TP53; the disease is pancreatic neoplasm.